AstraZeneca’s immunotherapy drug, Imfinzi, has shown promise in extending the lives of early-stage lung cancer patients by nearly two years, a significant finding revealed at a recent clinical trial. The drug was used after initial chemotherapy and radiation treatments on patients suffering from small cell lung cancer,
Illumina board gives its approval. Grail subsidiary
Taking into consideration whatever magnesium does for your body, getting sufficient in your diet plan is critical. But just how much is enough?
can be manipulated to engineer drugs that change gene expressions. This drug class is now well-established, and companies like GSK are making it a core element in their development plans, alongside typical proteins and pills. GSK is also backing off cell therapies
GSK is building a case to bring back its cancer therapy, Blenrep. Study outcomes disclosed Sunday suggest that combining this therapy with two other key multiple myeloma drugs impeded disease progression more than using Takeda’s Velcade and the same drug cocktail
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!